How to buy OrCam stock when it goes public

How to buy OrCam stock when it starts trading

1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
2. Open your brokerage account. Complete an application with your details.
3. Confirm your payment details. Fund your account.
4. Research the stock. Find the stock by name or ticker symbol and research it before deciding if it's a good investment for you.
5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.

Finder's picks for buying OrCam stock when it goes public

Best for beginners

Go to site

---

• Min. deposit: $0
• Stock trade fee: $0
• Sign up bonus: Get up to $1,000 in stock when you fund a new account within 30 days

Best for options trading

Go to site

---

• Min. deposit: $0
• Stock trade fee: $0
• Sign up bonus: Get $100-$5,000 when you open an account with $5,000 to $1,000,000+

Our pick for cash sweep

Go to site

---

• Min. deposit: $0
• Stock trade fee: $0
• Sign up bonus: Get 5 or 15 free stocks when you open and fund an account with $100 or $1,000

How do similar companies perform?

It's impossible to predict how any stock will perform — and IPOs can be particularly volatile. Looking at the performance of similar companies can help you decide if now is a good time to buy OrCam stock.

• Nuance Communications (NUAN.US)

  Company summary

  Nuance Communications, Inc. provides conversational and cognitive artificial intelligence (AI) innovations that bring intelligence to everyday work and life. The company delivers solutions that understand, analyze, and respond to people - amplifying human intelligence to increase productivity and security. Its Healthcare segment provides clinical speech and clinical language understanding solutions that improve the clinical documentation process, from capturing the complete patient record to improving clinical documentation and quality measures for reimbursement. Its solutions include Dragon Medical One, cloud-based speech solution; computer-assisted physician documentation; diagnostic imaging solutions; Nuance Dragon Ambient eXperience, a voice-enabled solution; and clinical documentation improvement and coding. The company's Enterprise segment primarily engages in using speech, natural language understanding, and artificial intelligence to provide automated customer solutions and services for voice, mobile, web, and messaging channels. Its solutions include intelligent engagement solutions; Conversational AI; Engagement AI; and Security AI. Its Other segment provides voicemail transcription services. It serves organizations across healthcare, financial services, telecommunications, government, and retail. The company markets and sells its solutions and technologies directly through sales force, as well as through a network of resellers, including system integrators, independent software vendors, value-added resellers, distributors, hardware vendors, telecommunications carriers, and e-commerce Websites worldwide. The company was formerly known as ScanSoft, Inc. and changed its name to Nuance Communications, Inc. in October 2005. Nuance Communications, Inc. was incorporated in 1992 and is headquartered in Burlington, Massachusetts. As of March 4, 2022, Nuance Communications, Inc. operates as a subsidiary of Microsoft Corporation.

  Historical performance

  Stock information

  • Market capitalization: $17882421248
  • PEG ratio: 13.72
  • Dividend yield: 0%

  Get more detailed information and learn how to buy NUAN.US stock

• Medtronic (MDT.US)

  Company summary

  Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

  Historical performance

  Stock information

  • Market capitalization: $106052894720
  • P/E ratio: 25.8961
  • PEG ratio: 1.6116
  • Dividend yield: 0.0346%

  Get more detailed information and learn how to buy MDT.US stock

• Abbott Laboratories (ABT.US)

  Company summary

  Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

  Historical performance

  Stock information

  • Market capitalization: $182616162304
  • P/E ratio: 35.901
  • PEG ratio: 25.142
  • Dividend yield: 0.0194%

  Get more detailed information and learn how to buy ABT.US stock

Compare trading platforms

1 - 7 of 7

Sort by:

Name	Product	Ratings	Available asset types	Minimum deposit	Stock trade fee	Signup bonus
SoFi Invest® Finder Rating: 4.6 / 5: ★★★★★ SoFi Invest® Finder Rating: 4.6 / 5: ★★★★★		★★★★★	Stocks, Options, ETFs, Cryptocurrency	$0	$0	Get up to $1,000 in stock when you fund a new account within 30 days	Go to site More Info		loading Fetching your data...
tastytrade Finder Rating: 4.8 / 5: ★★★★★ tastytrade Finder Rating: 4.8 / 5: ★★★★★		★★★★★	Stocks, Options, ETFs, Cryptocurrency, Futures	$0	$0	Get $100-$5,000 when you open and fund an account with $5,000 to $1,000,000+	Highly commended for Best Derivatives Trading Platform award.	Go to site More Info		loading Fetching your data...
Moomoo Finder Rating: 4.7 / 5: ★★★★★ Moomoo Finder Rating: 4.7 / 5: ★★★★★ Exclusive		★★★★★	Stocks, Options, ETFs	$0	$0	Get 5 or 15 free stocks when you open and fund an account with $100 or $1,000	No commission stock and ETF trading, with a chance to get up to 16 free stocks with signup.	Go to site More Info		loading Fetching your data...
EXCLUSIVE eToro Finder Rating: 4.2 / 5: ★★★★★ eToro Finder Rating: 4.2 / 5: ★★★★★	EXCLUSIVE	★★★★★	Stocks, Options, ETFs, Cryptocurrency	$0	$0	FINDER EXCLUSIVE: Get a guaranteed $25 bonus when you sign up and deposit $100	Not available in NY, NV, MN, TN, and HI.	Go to site More Info		loading Fetching your data...
Public.com Finder Rating: 4 / 5: ★★★★★ Public.com Finder Rating: 4 / 5: ★★★★★		★★★★★	Stocks, ETFs, Cryptocurrency, Art, Treasury Bills, Collectibles	$0	$0	N/A	2.5% fee applies to all alternative asset transactions.	Go to site More Info		loading Fetching your data...
Robinhood Finder Rating: 4.2 / 5: ★★★★★ Robinhood Finder Rating: 4.2 / 5: ★★★★★		★★★★★	Stocks, Options, ETFs, Cryptocurrency	$0	$0	Get a free stock when you successfully sign up and link your bank account.	Make unlimited commission-free trades, plus earn 5% interest on uninvested cash in your account with Robinhood Gold. Subscription fees apply.	Go to site More Info		loading Fetching your data...
Wealthfront Finder Rating: 4 / 5: ★★★★★ Wealthfront Finder Rating: 4 / 5: ★★★★★		★★★★★	Stocks, ETFs	$500	$0	Get a $50 bonus when you fund your first taxable Automated Investing Account.	Automated stock and bond ETF investing with the ability to trade individual stocks for as little as $1 apiece.	Go to site More Info		loading Fetching your data...

loading

CompareClear

More on investing

How to buy FAANG stocks

{"menuItems":[{"label":"Latest Updates","anchorName":"#latest-updates"},{"label":"Best potash stocks to watch in 2023","anchorName":"#see"}]}

Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.

Read more…

How to buy soccer stocks

{"menuItems":[{"label":"Latest Updates","anchorName":"#latest-updates"},{"label":"Best potash stocks to watch in 2023","anchorName":"#see"}]}

A simple guide to buying stocks in your favorite European soccer team.

Read more…

Inflation stocks

{"menuItems":[{"label":"Latest Updates","anchorName":"#latest-updates"},{"label":"Best potash stocks to watch in 2023","anchorName":"#see"}]}

Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.

Read more…